Cipla launches Q-TIB globally

Cipla launches Q-TIB globally, a novel fixed dose combination in a single tablet for TB prophylaxis in HIV.

Read the Cipla's press release here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Cipla

Published: Dec. 6, 2017, 8:04 p.m.

Last updated: Dec. 6, 2017, 9:06 p.m.

Print Share